| Literature DB >> 25797348 |
Rekha Patel1, Alyssa Neill2, Hongcheng Liu2, Bruce Andrien2.
Abstract
Recombinant monoclonal antibodies (mAbs) have become an important category of biological therapeutics. mAbs share the same structures and biological functions as endogenous IgG molecules. One function is complement-dependent cytotoxicity (CDC) initiation by binding of C1q. Traditionally, ELISA methods have been utilized to measure C1q binding. A new robust capture method was established in this study to measure the binding affinity of C1q to antibodies by surface plasmon resonance (SPR). The utility of this method was demonstrated by determination of the difference in IgG subclass specificity of C1q binding.Entities:
Keywords: C1q; Complement dependent cytotoxicity; Monoclonal antibodies; Surface plasmon resonance
Mesh:
Substances:
Year: 2015 PMID: 25797348 DOI: 10.1016/j.ab.2015.03.012
Source DB: PubMed Journal: Anal Biochem ISSN: 0003-2697 Impact factor: 3.365